bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

BIAF · Nasdaq

bioAffinity Technologies, Inc. (BIAF) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for bioAffinity Technologies, Inc. in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 89 days

EPS estimate

-2.10

Revenue estimate

1.9M

Past earnings

07 Aug 2026
EPS actual
-0.64 (+69.5%)
estimate -2.10
Revenue actual
1.5M (-11.2%)
estimate 1.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
08 May 2026
EPS actual
-0.81 (+66.3%)
estimate -2.40
Revenue actual
1.4M (-8.9%)
estimate 1.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
13 Mar 2026
EPS actual
5.98 (+321.5%)
estimate -2.70
Revenue actual
1.6M (+2.5%)
estimate 1.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
14 Nov 2025
EPS actual
-4.74 (-75.6%)
estimate -2.70
Revenue actual
1.4M (+2.5%)
estimate 1.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

bioAffinity Technologies beat consensus estimates on EPS but missed on revenue, posting a loss per share of $0.64 versus an expected $2.10 loss and revenue of $1.51 million, which fell 11.2% short of expectations. In the prior quarter, EPS also came in ahead of expectations while revenue was below estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

Sector
Healthcare
Industry
Medical diagnostics research
Country
United States
Exchange
Nasdaq
CEO
Maria Zannes
Employees
57
IPO date
01 Sep 2022
ISIN
US09076W3079
Website
bioaffinitytech.com

Frequently asked questions

When does bioAffinity Technologies, Inc. (BIAF) next report earnings?

bioAffinity Technologies, Inc. (BIAF) is scheduled to report earnings on November 18, 2026.

What was bioAffinity Technologies, Inc.'s most recent earnings date?

bioAffinity Technologies, Inc. (BIAF) last reported earnings on August 7, 2026.

Where is bioAffinity Technologies, Inc. stock listed?

bioAffinity Technologies, Inc. (BIAF) is listed on Nasdaq.